Delos Wealth Advisors’s ICU Medical ICUI Stock Holding History

Delos Wealth Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50	Closed	-$12K	–	336
2021 Q4	$12K	Buy	+50	New	+$11.7K	0.01%	190

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Delos Wealth Advisors's ICUI Position: Q1 2022 in Review

Delos Wealth Advisors sold out of ICU Medical (ICUI) in Q1 2022, closing a stake of 50 shares — an estimated $12K sold.

Delos Wealth Advisors first reported a position in ICUI in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 295 funds tracked by Wall St. Rank hold ICUI as of Q1 2022.

Delos Wealth Advisors reported no remaining ICU Medical position as of Q1 2022 after selling out during the quarter.
Delos Wealth Advisors sold 50 ICU Medical shares in Q1 2022, an estimated $12K.
Delos Wealth Advisors first reported a position in ICU Medical in Q4 2021 and held it in 1 quarter.
Delos Wealth Advisors's ICU Medical position peaked at $12K in Q4 2021.
295 funds tracked by Wall St. Rank held ICU Medical as of Q1 2022.

Based on Delos Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.